猪瘟兔化弱毒株E2基因的原核表达及间接ELISA的初步建立

猪瘟病毒E2蛋白C端含有一段30多个疏水性氨基酸组成的跨膜区域(Transmembrane region,TMR),用RT-PCR和巢式PCR分别扩增了含不同长度TMR的猪瘟兔化弱毒E2基因,并克隆入pGEX-4T-1的MCS中,构建了原核表达载体pGEXTE2-339(无TMR)、pGEXTE2-355(1TMR)、pGEXTE2-375(3TMR).因E2基因含有大量大肠杆菌稀有密码子,选择了BL21-CodonPlus(DE3)-RP作为表达受体菌,结果表明pGEXTE2-339、pGEXTE2-355以包涵体的形式正确表达了目的蛋白,而pGEXTE2-375没有明显表达.并利用pGEXTE2-339、pGEXTE2-355表达的融合蛋白初步建立了间接ELISA方法.     

抗人红细胞单链抗体与猪瘟E2蛋白双功能融合蛋白的构建及生物学活性检测

为构建具有凝集性、免疫反应性的双功能融合蛋白,本研究采用重叠延伸PCR方法将2E8ScFv(抗人红细胞H抗原单链抗体基因)和mE2(猪瘟病毒E2蛋白主要抗原编码区基因)拼接成融合基因2E8mE2,并插入原核表达载体pET-DsbA,将重组表达质粒pET-DsbA-2E8mE2转化入大肠杆菌Escherichia coli BL21(DE3)PlysS中进行IPTG诱导表达,表达的融合蛋白经SDS-PAGE和Western blotting分析鉴定,结果表明:2E8mE2融合基因在大肠杆菌中获得了表达,表达产物以包涵体形式存在,分子量约为65kDa,与预期的大小一致。分别采用亲和层析法和谷胱甘肽再氧化法对融合蛋白进行纯化和复性,红细胞凝集试验证实:2E8mE2融合蛋白复性效果良好,既能够与人红细胞结合,又能够与猪瘟病毒抗体反应,具有双功能特性。     

猪瘟病毒E0蛋白的原核表达及其间接ELISA方法的建立

表达猪瘟病毒保护性抗原E0蛋白用以建立猪瘟抗体诊断方法,在标记疫苗(Marker vaccine)的研制和应用上具有重要的血清学鉴别功能,对于监测猪瘟病毒的流行情况和疫苗免疫情况及制定免疫程序具有重要作用.将猪瘟兔化弱毒株(HCLV)E0基因分别插入原核表达质粒pGEX4T,pET30,pMAL-p2X中,并分别以BL21和BL21-codonplus(DE3)-RP, BL21(DE3)和BL21-codonplus(DE3)-RP,TB1和BL21-codonplus(DE3)-RP为表达菌株.通过摸索IPTG诱导浓度,诱导温度,菌体收获时间,确定E0基因能在pGEX4T/ BL21-codonplus(DE3)-RP和pMAL-p2X/ BL21-codonplus(DE3)-RP中获得高效表达,表达产量分别占菌体总蛋白的15%和30%,表达的重组蛋白主要为包涵体形式.分别采用B-per试剂和超声波裂解配以曲通尿素对包涵体进行洗涤两种方法在pGEX表达系中取得了较好的效果.使用分步透析法对变性的包涵体进行复性,将复性蛋白过GST亲和层析柱得到纯化的GST-E0融合蛋白.以GST-E0融合蛋白为诊断抗原,通过摸索抗原包被浓度,抗体血清稀释倍数初步建立了用间接ELISA检测猪瘟血清E0抗体的方法,为进一步开发猪瘟抗体检测试剂盒奠定基础.     

猪瘟病毒E0蛋白的原核表达及其间接ELISA方法的建立

表达猪瘟病毒保护性抗原E0蛋白用以建立猪瘟抗体诊断方法,在标记疫苗(Marker vaccine)的研制和应用上具有重要的血清学鉴别功能,对于监测猪瘟病毒的流行情况和疫苗免疫情况及制定免疫程序具有重要作用.将猪瘟兔化弱毒株(HCLV)E0基因分别插入原核表达质粒pGEX4T,pET30,pMAL-p2X中,并分别以BL21和BL21-codonplus(DE3)-RP, BL21(DE3)和BL21-codonplus(DE3)-RP,TB1和BL21-codonplus(DE3)-RP为表达菌株.通过摸索IPTG诱导浓度,诱导温度,菌体收获时间,确定E0基因能在pGEX4T/ BL21-codonplus(DE3)-RP和pMAL-p2X/ BL21-codonplus(DE3)-RP中获得高效表达,表达产量分别占菌体总蛋白的15%和30%,表达的重组蛋白主要为包涵体形式.分别采用B-per试剂和超声波裂解配以曲通尿素对包涵体进行洗涤两种方法在pGEX表达系中取得了较好的效果.使用分步透析法对变性的包涵体进行复性,将复性蛋白过GST亲和层析柱得到纯化的GST-E0融合蛋白.以GST-E0融合蛋白为诊断抗原,通过摸索抗原包被浓度,抗体血清稀释倍数初步建立了用间接ELISA检测猪瘟血清E0抗体的方法,为进一步开发猪瘟抗体检测试剂盒奠定基础.     

含CSFV E2基因A/D区原核表达载体的构建、表达及其抗原性研究

应用RT PCR方法扩增了编码猪瘟病毒石门株 (CSFVshimenstrain)囊膜糖蛋白E2全基因 ,然后将其克隆到pMD 1 8T质粒中 ,获得重组质粒pMD E2。再以pMD E2为模板 ,另行设计两对引物 ,同时扩增其中一段适于在E .coli中表达且抗原反应性较好的基因片段 (E2蛋白A D抗原区基因序列 ) ,将扩增的两片段串联插入原核表达载体pET 32a中构建成重组质粒pET 2e。用酶切和序列分析鉴定插入目的基因的正确性。SDS PAGE和Western blot分析表明 ,经pET 2e转化、IPTG诱导的受体菌可表达目的蛋白 ,克隆在硫氧还蛋白 (thioredoxinprotein ,TrxA)基因下游的E2蛋白基因与TrxA基因获得了高效融合表达 ,并且具有免疫学反应活性 ,这为猪瘟的血清学诊断方法的建立打下了基础 。     

甘薯细胞色素P450单加氧酶基因IbCYP714E1和IbCYP714E2的鉴定及表达分析

CYP714基因在植物赤霉素合成与代谢过程中发挥着重要作用。该研究从甘薯基因组中鉴定出2个CYP714基因,对基因的结构和编码蛋白质的理化性质等进行了生物信息学分析,并利用荧光定量PCR(qRT-PCR)技术分析基因在不同组织和非生物胁迫条件下的表达特征,为解析甘薯CYP714基因的生物学功能提供帮助。结果表明:(1)2个基因为分别编码518个和521个氨基酸的碱性亲水蛋白,被亚细胞定位于细胞质中;(2)2个蛋白质均含有CYP714蛋白亚家族的3个特征结构域,与毛白杨的PtCYP714E2、PtCYP714E4和PtCYP714E5蛋白聚为一类,分别定名为IbCYP714E1和IbCYP714E2;(3)荧光定量PCR分析显示,IbCYP714E1和IbCYP714E2基因的表达部位存在一定差异,IbCYP714E1在柴根、初生根和叶片中表达量较高,而IbCYP714E2基因只在柴根和花上表达量较高,在盐和干旱胁迫下,IbCYP714E1基因表达量均增加,而IbCYP714E2基因只在盐胁迫条件下表达量增加。IbCYP714E1和IbCYP714E2基因可能参与赤霉素的降解和对非生物胁迫的应答。     

针对猪瘟病毒E2蛋白的嵌合猪源化单克隆抗体的表达及抗病毒活性鉴定

猪瘟(Classical swine fever,CSF)是严重危害养猪业的一种烈性传染病,常造成巨大的经济损失,是世界动物卫生组织要求必须申报的动物疫病之一。猪瘟的病原是猪瘟病毒(Classical swine fever virus,CSFV),CSFV的结构蛋白由衣壳蛋白(C)和囊膜糖蛋白(E~(rns)、E1、E2)构成。E2蛋白是CSFV主要的保护性抗原,可以诱导机体产生中和抗体,从而抵抗CSFV的感染。此前,本团队制备了一株针对CSFV E2蛋白的鼠源单克隆抗体HQ06。文中将HQ06抗体重链和轻链可变区基因与猪源恒定区基因嵌合后克隆至真核表达载体,利用中国仓鼠卵巢(CHO)细胞制备一株针对CSFV E2蛋白的嵌合猪源化单克隆抗体c HQ06。应用ELISA、Western blotting试验证实了c HQ06与CSFV E2蛋白具有良好的反应性;中和试验结果表明c HQ06可以中和CSFV。综上所述,本研究应用CHO细胞稳定表达了具有良好反应性和中和活性的针对CSFV E2蛋白的嵌合猪源化单克隆抗体c HQ06,为研究CSFV E2蛋白结构、功能以及开发新型的CSFV诊断和治疗制剂奠定基础。     

猪瘟病毒E2蛋白A／D抗原区基因在酵母中的分泌表达与鉴定

基于猪瘟病毒主要保护性抗原E2囊膜糖蛋白有两个相对独立的抗原结构单位-B／C抗原区和A／D抗原区,设计一对特异性的引物扩增猪瘟病毒E2蛋白的A／D抗原区基因,并将PCR产物克隆入含有强启动子PAOX1和α-MF信号肽序列的巴斯德毕赤酵母表达载体pPICZαC中,构建成重组质粒pPICZα-AD,酶切线性化后电穿孔导入巴斯德毕赤酵母X33菌中,经Zeocin^TM筛选得到5株高拷贝转化子,甲醇诱导表达。SDS-PAGE和Western blot试验表明酵母培养上清液中含有具有良好反应原性的E2蛋白,蛋白表达量达175．8μg／mL。N-糖基化分析显示该表达蛋白在分泌过程中发生糖基化。该研究为研制防治猪瘟的亚单位疫苗与诊断试剂盒奠定基础。     

猪瘟病毒E2蛋白A/D抗原区基因在酵母中的分泌表达与鉴定

基于猪瘟病毒主要保护性抗原E2囊膜糖蛋白有两个相对独立的抗原结构单位-B/C抗原区和A/D抗原区,设计一对特异性的引物扩增猪瘟病毒E2蛋白的A/D抗原区基因,并将PCR产物克隆入含有强启动子PAox1和α-MF信号肽序列的巴斯德毕赤酵母表达载体pPICZαC中,构建成重组质粒pPICZα-AD,酶切线性化后电穿孔导入巴斯德毕赤酵母X33菌中,经ZeocinTM筛选得到5株高拷贝转化子,甲醇诱导表达.SDS-PAGE和Westernblot试验表明酵母培养上清液中含有具有良好反应原性的E2蛋白,蛋白表达量达175.8μg/mL.N-糖基化分析显示该表达蛋白在分泌过程中发生糖基化.该研究为研制防治猪瘟的亚单位疫苗与诊断试剂盒奠定基础.     

猪瘟病毒E2蛋白B/C抗原区基因在毕赤酵母中的表达与鉴定

基于猪瘟病毒主要保护性抗原---E2囊膜糖蛋白有两个相对独立的抗原结构单位---B/C抗原区和A/D抗原区 ,设计引物扩增编码猪瘟病毒E2蛋白B/C抗原区的基因 ,将大小为261bp的PCR产物插入含有强启动子P_AOX1和α-MF信号肽序列的巴斯德毕赤酵母 (Pichiapastoris)表达载体pPICZαC中 ,构建成重组质粒pPICZα-BC ,酶切线性化后电穿孔导入巴斯德毕赤酵母菌X₃₃ 中 ,经Zeocin^TM 筛选得到 3株高拷贝转化子 ,甲醇诱导表达 ,SDS-PAGE和Westernblot及ELISA试验表明 ,酵母培养上清液中含有具有良好反应原性的E2蛋白。为研究亚单位疫苗或诊断抗原打下坚实基础。     

猪瘟病毒E2基因的定点突变、在大肠杆菌中的高效表达及表达产物的免疫原性

用重组PCR技术对猪瘟病毒石门株E2基因进行了定点突变, 然后将突变后的基因克隆至表达载体质粒pET-28a(+)中,构建成重组质粒pETE2。将pETE2转入受体菌BL21(DE3)plysS中,在IPTG的诱导下, 重组转化菌可高效表达目的基因, 表达量平均可达菌体蛋白总量的28%。免疫印迹和间接ELISA表明所表达的蛋白是CSFV特异性的。此重组蛋白免疫的家兔可抵抗猪瘟兔化弱毒的攻击。     

猪瘟病毒E2基因真核表达质粒的构建及基因疫苗的研究

构建了猪瘟（ｃｌａｓｓｉｃａｌ ｓｗｉｎｅ ｆｅｖｅｒ ｖｉｒｕｓ,ＣＳＦＶ）主要保护性抗原Ｅ２基因４种不同的真核表达质粒。小鼠免疫试验表明,Ｅ２基因上不同的功能区对基因疫苗的免疫应答有很大影响,有信号肽序列的Ｅ２基因可诱导产生特异性免疫反应,且无跨膜区序列的Ｅ２基因所诱导的免疫应答反应比有跨膜区序列的强,而无信号肽序列的Ｅ２基因则不能诱导产生ＣＳＦＶ特异性的免疫反应。攻毒保护试验表明,免疫家兔最     

猪瘟病毒E2蛋白A3BCD主要抗原结构域的原核表达

目的：对猪瘟病毒E2蛋白A3BCD进行原核表达,以期获得具有抗原活性的表达产物。方法：利用反转录PCR（RT-PCR）和套式PCR（nPCR）技术从河南省近期流行猪瘟病毒野毒株中扩增得到E2基因,并将其克隆至pUCm-T载体,构建克隆载体pUCm-TE2;利用PCR方法扩增E2基因的主要抗原域A3BCD,克隆至pET-32a（＋）载体,构建表达载体pET-32aE2-2,转化到大肠杆菌Rosetta（DE3）中,用IPTG进行诱导表达,对诱导产物进行SDS-PAGE和Western-blotting分析。结果：SDS-PAGE结果显示在相对分子质量约35000处出现预期条带,表达产物主要以包涵体形式存在;Western-blotting检测表明,表达产物能与猪瘟病毒阳性血清发生特异性反应,出现单一反应带;用8mol／L尿素（pH8.0）溶解包涵体,经Ni-NTA亲和层析法纯化,获得纯度较高的目的蛋白,ELISA检测表明能与猪瘟抗体阳性血清发生特异性反应。结论：重组质粒pET-32aE2-2转化大肠杆菌Rosetta（DE3）,解除了由于稀有密码子造成的表达限制,表达量得到提高;表达产物为硫氧还蛋白和E2-2的融合蛋白,易于纯化,且具有活性,为研制猪瘟抗体ELISA检测试剂盒奠定了基础。     

Secretory expression of E2 main antigen domain of CSFV C strain and the establishment of indirect ELISA assay

The sequence encoding an E2 main antigen glycoprotein of the C strain of classical swine fever virus (CSFV) was highly expressed in the host cell E. coli BL21-CodonPlus (DE3)-RIL using the pGEX-4T-1 expression vector and the soluble recombinant product was purified with Glutathione Sepharose TM<'4B> by centrifugation. The soluble recombinant protein showed good immune reactions and was confirmed by Western blot using anti-CSFV-specific antibodies. Then an indirect ELISA with the purified E2 protein as the coating antigen was established to detect antibody against CSFV. The result revealed that the optimal concentration of coated antigen was 0.6 μg/well and the optimal dilution of serum was 1:80. The positive cut-off value of this ELISA assay was OD<,tested serum>/OD<,negative serum>≥2.1- The E2-ELISA method was evaluated by comparison with the indirect hemagglutination test (IHAT). When a total of 100 field serum samples were tested the sensitivity and specificity were 90.3% and 94.7% respectively. Specificity analysis showed that there were no cross-reactions between BVD serum and the purified E2 protein in the E2-ELISA.     

含双拷贝CSFV E2基因A和D片段原核表达载体的构建及表达

猪瘟是严重危害养猪业的传染病,该病具有高度接触传染性,其流行性广,发病率高,死亡率高,危害极大,被世界动物卫生组织(OIE)列为A类传染病之一。本病的主要临床特征是高热、实质器官出血、淋巴细胞和血小板减少,而怀孕母猪多发生繁殖防碍。每年,猪瘟的发生都为国家造成巨大的经济损失。猪瘟的病原是猪瘟病毒,属于黄病毒科瘟病毒属成员,是单股正链RNA病毒[1]。囊膜糖蛋白E2是猪瘟病毒的主要保护性抗原[2,3]。E2蛋白可诱导机体产生坚强的中和性免疫保护,具有良好的免疫原性和反应原性[4~6] ,这为本病的诊断提供了重要的分子生物学及免疫学…     

猪瘟兔化弱毒E2蛋白A／D区的高效表达和蛋白纯化及其应用

本试验对表达猪瘟E2囊膜糖蛋白的原核表达载体pET—E2的表达条件进行了优化,在此基础上,对表达的蛋白质进行了纯化。在6mol/L盐酸胍存在的条件下,将包涵体溶解在Tris-HCl中,并直接用于His Band亲和层析。收集过柱产物并透析,在2％SDS条件下,对所得的重组蛋白质进行了定量。重组蛋白质被用来包被96孔ELISA板并应用于免疫猪瘟抗体水平的测定。     

Production of Classical Swine Fever Virus Envelope Glycoprotein E2 as Recombinant Polyhedra in Baculovirus-Infected Silkworm Larvae

Although, classical swine fever virus (CSFV) envelope glycoprotein E2 subunit vaccine has been developed using the baculovirus expression system, the expression of viral antigens in baculovirus-infected insect cells is often ineffective. Therefore, an alternative strategy to the traditional baculovirus expression system is needed that is more productive and effective. Here, we report a novel strategy for the large-scale production of a CSFV E2 in the larvae of a baculovirus-infected silkworm, Bombyx mori. We constructed a recombinant B. mori nucleopolyhedrovirus (BmNPV) that expressed recombinant polyhedra together with the N-terminal 179 amino acids of CSFV E2 (E2ΔC). BmNPV-E2ΔC-infected silkworm larvae expressed native polyhedrin and approximately 44-kDa fusion protein that was detected using both anti-polyhedrin and anti-CSFV E2 antibodies. Electron and confocal microscopy both demonstrated that the recombinant polyhedra contained both the fusion protein and native polyhedrin were morphologically normal and contained CSFV E2ΔC. The CSFV E2ΔC antigen produced in BmNPV-E2ΔC-infected silkworm larvae reached 0.68?mg/ml of hemolymph and 0.53?mg/larva at 6-days post-infection. Six-week-old female BALB/c mice that were immunized with the E2ΔC protein purified from solubilized recombinant polyhedra elicited CSFV E2 antibodies, which indicated that the CSFV E2ΔC protein from recombinant polyhedra was immunogenic. The virus neutralization test showed that the serum from mice that were treated with E2ΔC protein from recombinant polyhedra contained significant levels of virus neutralization activity. These results demonstrate that this strategy can be used for the large-scale production of CSFV E2 antigen.     

Expression of Major Antigen Domains of Gene of E2 CSFV and Analysis of its Immunological Activity

E2 is an envelope glycoprotein of Classical swine fever virus (CSFV) and contains sequential neutralizing epitopes to induce virus-neutralizing antibodies and mount protective immunity in the natural host. In this study, four antigen domains (ABCD) of the E2 gene was cloned from CSFV Shimen strain into the retroviral vector pBABE puro and expressed in eukaryotic cell (PK15) by an retroviral gene expression system, and the activity of recombinant E2 protein to induce immune responses was evaluated in rabbits. The results indicated that recombinant E2 protein can be recognized by fluorescence antibodies of CSFV and CSFV positive serum (Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China) using Western blot, indirect immunofluorescence antibody test (IFAT) and ELISA, Furthermore, anti-CSFV specific antibodies and lymphocyte proliferation were elicited and increased by recombinant protein after vaccination. In the challenge test, all of rabbits vaccinated with recombinant protein and Chinese vaccine strain (C-strain) were fully protected from a rabbit spleen virus challenge. These results indicated that a retroviral-based epitope-vaccine carrying the major antigen domains of E2 is able to induce high level of epitope-specific antibodies and exhibits similar protective capability with that induced by the C-strain, and encourages further work towards the development of a vaccine against CSFV infection.     

猪瘟病毒NS3基因克隆、原核表达及间接ELISA方法初步建立

采用PCR方法从携带猪瘟病毒兔化弱毒(Hog cholera lapinized virus,HCLV)全长基因组cDNA的质粒pPOHCLV中扩增到长度为2000bp左右NS3基因序列,并将其克隆至原核表达载体pET-32a(+),构建成重组原核表达载体pETNS3。将pETNS3在大肠杆菌Rosetta(DE3)中进行优化表达,SDS-PAGE分析重组蛋白NS3主要以包涵体形式表达,分子大小约95kD。Western Blotting分析表明重组蛋白NS3具有免疫原性。采用Ni+亲和层析方法纯化得到重组蛋白NS3(90%)。以纯化的重组蛋白NS3为抗原初步建立了检测CSFVNS3抗体的间接ELISA方法,检测221份不同猪群和年龄猪的血清样品。检测结果与IDEXX公司CSFV-Ab检测试剂盒检测结果进行对比,阳性符合率为83.33%,阴性符合率为89.38%,总符合率为86.43%。30份存在差异的血清样品用间接免疫荧光法(Indirect immunofluorescence assay,IFA)进行检测,结果显示IFA检测结果与NS3间接ELISA和IDEXX公司CSFV-Ab检测试剂盒符合率分别为56.67%和43.33%。     

Expression of major antigen domains of E2 gene of CSFV and analysis of its immunological activity

E2 is an envelope glycoprotein of Classical swine fever virus (CSFV) and contains sequential neutralizing epitopes to induce virus-neutralizing antibodies and mount protective immunity in the natural host. In this study, four antigen domains (ABCD) of the E2 gene was cloned from CSFV Shimen strain into the retroviral vector pBABE puro and expressed in eukaryotic cell (PK15) by an retroviral gene expression system, and the activity of recombinant E2 protein to induce immune responses was evaluated in rabbits. The results indicated that recombinant E2 protein can be recognized by fluorescence antibodies of CSFV and CSFV positive serum (Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China) using Western blot, indirect immunofluorescence antibody test (IFAT) and ELISA, Furthermore, anti-CSFV specific antibodies and lymphocyte proliferation were elicited and increased by recombinant protein after vaccination. In the challenge test, all of rabbits vaccinated with recombinant protein and Chinese vaccine strain (C-strain) were fully protected from a rabbit spleen virus challenge. These results indicated that a retroviral-based epitope-vaccine carrying the major antigen domains of E2 is able to induce high level of epitope-specific antibodies and exhibits similar protective capability with that induced by the C-strain, and encourages further work towards the development of a vaccine against CSFV infection. Foundation items: The National “973” (2005CB523201); Key Technology R&D Programme (2006BAD06A03).